News
09-30-2010, 07:02 AM
Researchers have identified a novel, dual-platform technology, the On-Q-ity Circulating Cancer Capture and Characterization Chip (C5), which they believe is more efficient than the commonly used single-platform device in identifying circulating tumor cells (CTCs) in breast cancer...
More... (http://mnt.to/f/3KyZ)
More... (http://mnt.to/f/3KyZ)